FOXO TECHNOLOGIES INC. Increase (Decrease) in Other Accounts Payable
FOXO TECHNOLOGIES INC. (FOXO) reported Increase (Decrease) in Other Accounts Payable of $2.27 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayable · last filed 2022-08-12
- FOXO TECHNOLOGIES INC. increase (decrease) in other accounts payable for the quarter ending 2022-06-30 was $589.56K.
- FOXO TECHNOLOGIES INC. increase (decrease) in other accounts payable for the quarter ending 2022-03-31 was $1.68M, a 99.95% decline year-over-year.
- FOXO TECHNOLOGIES INC. increase (decrease) in other accounts payable for the quarter ending 2021-12-31 was $150.39K.
- FOXO TECHNOLOGIES INC. increase (decrease) in other accounts payable for the quarter ending 2021-09-30 was $123.68K.
- FOXO TECHNOLOGIES INC. increase (decrease) in other accounts payable for fiscal 2021 was $286.11K.
| Period end | Increase (Decrease) in Other Accounts Payable 2 month | Increase (Decrease) in Other Accounts Payable 3 month | Increase (Decrease) in Other Accounts Payable 3 month as first filed | Increase (Decrease) in Other Accounts Payable 5 month | Increase (Decrease) in Other Accounts Payable 6 month | Increase (Decrease) in Other Accounts Payable 8 month | Increase (Decrease) in Other Accounts Payable 9 month | Increase (Decrease) in Other Accounts Payable 12 month |
|---|---|---|---|---|---|---|---|---|
| 2022-06-30 | $589.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $2.27M 10-Q · filed 2022-08-12 | $2.42M derived: sum of 3 quarters · filed 2022-08-12 | $2.54M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2022-03-31 | $1.68M 10-Q · filed 2022-05-16 | $1.83M derived: sum of 2 quarters · filed 2022-05-16 | $1.95M derived: sum of 3 quarters · filed 2022-05-16 | -$3.48B derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-12-31 | $150.39K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $274.07K derived: sum of 2 quarters · filed 2022-03-07 | -$3.48B derived: sum of 3 quarters · filed 2022-08-12 | $286.11K 10-K · filed 2022-03-07 | ||||
| 2021-09-30 | $123.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$3.48B derived: sum of 2 quarters · filed 2022-08-12 | $135.72K 10-Q · filed 2021-11-15 | |||||
| 2021-06-30 | -$3.48B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $12.04K 10-Q · filed 2022-08-12 | ||||||
| 2021-03-31 | $3.48B 10-Q · filed 2022-05-16 | $34.81K 10-Q · filed 2021-05-17 | ||||||
| 2020-12-31 | $23.38K 10-K · filed 2022-03-07 | |||||||
| 2020-09-30 | $50.00K 10-Q · filed 2021-11-15 | |||||||
| 2020-06-30 | $50.00K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |